Substance P and substance P receptors in bone and gingival tissues

被引:11
作者
Goto T. [1 ]
Kido M.A. [1 ]
Yamaza T. [1 ]
Tanaka T. [1 ]
机构
[1] Laboratory of Oral Anatomy and Cell Biology, Graduate School of Dental Science, Kyushu University
来源
Medical Electron Microscopy | 2001年 / 34卷 / 2期
关键词
Bone; Gingival tissue; Junctional epithelium; Neurokinin-1; receptor; Osteoclast; Substance P;
D O I
10.1007/s007950170001
中图分类号
学科分类号
摘要
Substance P (SP) is an important member of the tachykinin family of neuropeptides, which work as neurotransmitters or neuromodulators. Recent advances in the analysis of SP receptors, particularly the neurokinin-1 receptors (NK1-Rs) that have high affinity for SP, have demonstrated that they are distributed not only in the cells of the neuronal or immune systems but also in peripheral cells. Therefore, the effect of SP and its cellular receptors is not limited to the nervous or immune systems, but is more extensive than previously appreciated. SP-like immunoreactive (SP-LI) axons have been localized in both bone and gingival tissue, and SP receptors are widely distributed in osteoclasts, osteoblasts, and junctional epithelial cells, as well as in neutrophils and endothelial cells. The distribution of SP-LI axons and SP receptors suggests that SP may directly modulate bone metabolism and gingival tissue functions through SP receptors.
引用
收藏
页码:77 / 85
页数:8
相关论文
共 78 条
  • [1] Maggi C.A., Patacchini R., Rovero P., Giachetti A., Tachykinin receptors and tachykinin receptor antagonists, J Auton Pharmacol, 13, pp. 23-93, (1993)
  • [2] Otsuka M., Yoshioka K., Neurotransmitter functions of mammalian tachykinins, Physiol Rev, 73, pp. 229-308, (1993)
  • [3] Cascieri M.A., Huang R.R., Fong T.M., Cheung A.H., Sadowski S., Ber E., Strader C.D., Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors, Mol Pharmacol, 41, pp. 1096-1099, (1992)
  • [4] Von Euler U.S., Gaddum J.H., An unidentified depressor substance in certain tissue extracts, J Physiol, 72, pp. 74-89, (1931)
  • [5] Brimijoin S., Lundberg J.M., Brodin E., Hokfelt T., Nilsson G., Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig, Brain Res, 191, pp. 443-457, (1980)
  • [6] Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J., Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia, Br J Pharmacol, 115, pp. 1265-1275, (1995)
  • [7] Brodin E., Gazelius B., Olgart L., Nilsson G., Tissue concentration and release of substance P-like immunoreactivity in the dental pulp, Acta Physiol Scand, 111, pp. 141-149, (1981)
  • [8] Lembeck F., Holzer P., Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation, Arch Pharmacol, 310, pp. 175-183, (1979)
  • [9] Jancso N., Jancso-Gabor A., Szolcsanyi J., Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin, Br J Pharmacol, 31, pp. 138-151, (1967)
  • [10] Buck S.H., Burcher E., The tachykinins